Abstract
The effect of CO on the expression of iNOS and COX-2 was investigated by using a CO-releasing molecule (CORM)-2 in LPS-activated RAW 264.7 cells in vitro. Interestingly, CORM-2 significantly inhibited iNOS (NO) but not COX-2 (PGE(2)) expression. PPAR-gamma activators such as troglitazone, GW1929, and 15-deoxy-Delta12, 14- prostaglandin J(2) showed preferential inhibitory effect on iNOS over COX-2 expression in LPS-activated macrophages. The same effect was shown in lung tissues (iNOS, COX-2) and serum (NO, PGE(2)) when administered of CORM-2 in LPS-induced septic mice, indicating that CO derived from CORM-2 differentially regulates iNOS and COX-2 through PPAR-gamma activation under inflammation state.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Carbon Monoxide / pharmacology*
-
Cell Line
-
Cyclooxygenase 2 / biosynthesis*
-
Endotoxemia / chemically induced
-
Endotoxemia / metabolism
-
Endotoxemia / pathology
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Regulation, Enzymologic / drug effects*
-
Lipopolysaccharides / physiology*
-
Macrophages, Alveolar / drug effects
-
Macrophages, Alveolar / metabolism*
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Nitric Oxide Synthase Type II / antagonists & inhibitors*
-
Nitric Oxide Synthase Type II / biosynthesis
-
Organometallic Compounds / metabolism
-
Organometallic Compounds / pharmacology*
-
PPAR gamma / metabolism*
Substances
-
Enzyme Inhibitors
-
Lipopolysaccharides
-
Organometallic Compounds
-
PPAR gamma
-
tricarbonyldichlororuthenium (II) dimer
-
Carbon Monoxide
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse
-
Ptgs2 protein, mouse
-
Cyclooxygenase 2